199 related articles for article (PubMed ID: 36303184)
21. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
22. A Killer Disarmed: Natural Killer Cell Impairment in Myelodysplastic Syndrome.
Arellano-Ballestero H; Sabry M; Lowdell MW
Cells; 2023 Feb; 12(4):. PubMed ID: 36831300
[TBL] [Abstract][Full Text] [Related]
23. Gene of the month: T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT).
Bolm L; Petruch N; Sivakumar S; Annels NE; Frampton AE
J Clin Pathol; 2022 Apr; 75(4):217-221. PubMed ID: 35058314
[TBL] [Abstract][Full Text] [Related]
24. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.
Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P
Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014
[TBL] [Abstract][Full Text] [Related]
25. CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.
Gleason MK; Ross JA; Warlick ED; Lund TC; Verneris MR; Wiernik A; Spellman S; Haagenson MD; Lenvik AJ; Litzow MR; Epling-Burnette PK; Blazar BR; Weiner LM; Weisdorf DJ; Vallera DA; Miller JS
Blood; 2014 May; 123(19):3016-26. PubMed ID: 24652987
[TBL] [Abstract][Full Text] [Related]
26. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
27. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH
Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Pleyer L; Valent P; Greil R
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
[TBL] [Abstract][Full Text] [Related]
29. T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signaling.
Li M; Xia P; Du Y; Liu S; Huang G; Chen J; Zhang H; Hou N; Cheng X; Zhou L; Li P; Yang X; Fan Z
J Biol Chem; 2014 Jun; 289(25):17647-57. PubMed ID: 24817116
[TBL] [Abstract][Full Text] [Related]
30. Bone marrow stromal cells from MDS and AML patients show increased adipogenic potential with reduced Delta-like-1 expression.
Weickert MT; Hecker JS; Buck MC; Schreck C; Rivière J; Schiemann M; Schallmoser K; Bassermann F; Strunk D; Oostendorp RAJ; Götze KS
Sci Rep; 2021 Mar; 11(1):5944. PubMed ID: 33723276
[TBL] [Abstract][Full Text] [Related]
31. Higher TIGIT+ γδ T
Hou Q; Wang P; Kong X; Chen J; Yao C; Luo X; Li Y; Jin Z; Wu X
Front Immunol; 2024; 15():1321126. PubMed ID: 38711501
[TBL] [Abstract][Full Text] [Related]
32. TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells.
Vendrame E; Seiler C; Ranganath T; Zhao NQ; Vergara R; Alary M; Labbé AC; Guédou F; Poudrier J; Holmes S; Roger M; Blish CA
AIDS; 2020 May; 34(6):801-813. PubMed ID: 32028328
[TBL] [Abstract][Full Text] [Related]
33. LacNAc modification in bone marrow stromal cells enhances resistance of myelodysplastic syndrome cells to chemotherapeutic drugs.
Li H; Ren X; Pang X; Yang P; Lu Y; Guan F; Wang Y; Li X
Biochim Biophys Acta Mol Cell Res; 2023 Aug; 1870(6):119492. PubMed ID: 37207914
[TBL] [Abstract][Full Text] [Related]
34. Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia.
Yao D; Xu L; Liu L; Zeng X; Zhong J; Lai J; Zheng R; Jin Z; Chen S; Zha X; Huang X; Lu Y
Biomed Res Int; 2020; 2020():9531549. PubMed ID: 33102599
[TBL] [Abstract][Full Text] [Related]
35. Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML.
Brauneck F; Seubert E; Wellbrock J; Schulze Zur Wiesch J; Duan Y; Magnus T; Bokemeyer C; Koch-Nolte F; Menzel S; Fiedler W
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884723
[TBL] [Abstract][Full Text] [Related]
36. Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation.
Boy M; Bisio V; Zhao LP; Guidez F; Schell B; Lereclus E; Henry G; Villemonteix J; Rodrigues-Lima F; Gagne K; Retiere C; Larcher L; Kim R; Clappier E; Sebert M; Mekinian A; Fain O; Caignard A; Espeli M; Balabanian K; Toubert A; Fenaux P; Ades L; Dulphy N
Nat Commun; 2023 Feb; 14(1):588. PubMed ID: 36737440
[TBL] [Abstract][Full Text] [Related]
37. Impact of Bone Marrow Natural Killer Cells (NK); Soluble TNF-α and IL-32 Levels in Myelodysplastic Syndrome Patients.
Aref S; Khaled N; Al Gilany AH; Ayed M; Abouzeid T; Attia D
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2949-2953. PubMed ID: 33112553
[TBL] [Abstract][Full Text] [Related]
38. Expression of the Inhibitory Receptor TIGIT Is Up-Regulated Specifically on NK Cells With CD226 Activating Receptor From HIV-Infected Individuals.
Yin X; Liu T; Wang Z; Ma M; Lei J; Zhang Z; Fu S; Fu Y; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
Front Immunol; 2018; 9():2341. PubMed ID: 30364127
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor β1-mediated functional inhibition of mesenchymal stromal cells in myelodysplastic syndromes and acute myeloid leukemia.
Geyh S; Rodríguez-Paredes M; Jäger P; Koch A; Bormann F; Gutekunst J; Zilkens C; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
Haematologica; 2018 Sep; 103(9):1462-1471. PubMed ID: 29773599
[TBL] [Abstract][Full Text] [Related]
40. CD155/TIGIT, a novel immune checkpoint in human cancers (Review).
Liu L; You X; Han S; Sun Y; Zhang J; Zhang Y
Oncol Rep; 2021 Mar; 45(3):835-845. PubMed ID: 33469677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]